Beyond Air Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Beyond Air Inc inventory turnover ratio, the Beyond Air Inc 's ability to sell and replace its inventory in the first quarter 2026, sequentially increased to 3.46 in the first quarter 2026, XAIR's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Beyond Air Inc in Jun 30 2026 quarter, has decreased to 105 days, compare to 120 days, in the Mar 31 2026 quarter.

Within Healthcare sector 123 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1386 in the fourth quarter 2026, to 1578.

XAIR Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Beyond Air Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

XAIR Inventory Turnover Ratio	(Jun 30 2026) I. Quarter	(Mar 31 2026) IV. Quarter	(Dec 31 2025) III. Quarter	(Sep 30 2025) II. Quarter	(Jun 30 2025) I. Quarter
Y / Y Inventory Growth	-46.9 %	-41.83 %	13.63 %	-11.79 %	1.76 %
Y / Y Cost of Sales Growth	-3.8 %	53.12 %	0 %	100 %	57.87 %
Inventory Turnover Ratio (TTM)	3.46	3.03	2.44	2.51	2.02
XAIR's Total Ranking	# 1578	# 1386	# 1573	# 1671	# 1882
Average inventory processing period	105	121	150	145	181
Seq. Inventory Growth	-8.11 %	-41.83 %	8.43 %	-8.38 %	0.66 %
Seq. Cost of Sales Growth	-14.89 %	81.3 %	-50 %	24.69 %	35.47 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 51
Healthcare Sector	# 124
Overall Market	# 1578

Inventory Turnover Ratio Statistics
High	Average	Low
3.51	1.87	0.64
(Jun 30 2026)		(Mar 31 2023)

XAIR Company Profile >> Back to XAIR Efficiency Comparisons >> Compare XAIR Inventory Turnover Ratio to its Competitors

Financial Statements
Beyond Air Inc 's Inventories	$ 1 Millions	Visit XAIR's Balance sheet
Beyond Air Inc 's Cost of Revenues TTM	$ 6 Millions	Visit XAIR's Income Statement
What are XAIR's Sales?		Visit XAIR's Sales by Segment

Other Inventory Turnover Ratios
Beyond Air Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
XAIR's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for XAIR's Competitors
Inventory Turnover Ratio for XAIR's Suppliers
Inventory Turnover Ratio for XAIR's Customers

You may also want to know
XAIR's Sales Growth Rates	XAIR's Pe Price to earnings ratio	XAIR's Receivables Turnover Ratio	XAIR's Stock Quote
XAIR's Net Income Growth Rates	XAIR's Ps Price to Sales ratio	XAIR's Sales per Employee	XAIR's Asset Turnover Ratio
XAIR's Net Margin	XAIR's Pb Price to Book ratio	XAIR's Financial Strength Ratios	XAIR's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2026	Inventories at quarter ending Jun 30 2026
Edap Tms Sa	12.79	$ 62.351 Millions	$ 5 Millions
Earth Science Tech Inc	11.64	$ 8.974 Millions	$ 1 Millions
Infusystem Holdings Inc	10.92	$ 60.985 Millions	$ 6 Millions
Irhythm Holdings Inc	10.79	$ 235.967 Millions	$ 22 Millions
Tarsus Pharmaceuticals Inc	10.20	$ 43.740 Millions	$ 4 Millions
Lantheus Holdings Inc	10.09	$ 619.325 Millions	$ 61 Millions
Sotera Health Company	10.04	$ 547.412 Millions	$ 55 Millions
Natera Inc	9.46	$ 672.186 Millions	$ 71 Millions
Warby Parker Inc	9.27	$ 414.054 Millions	$ 45 Millions
Hims and Hers Health Inc	9.23	$ 814.411 Millions	$ 88 Millions
Polomar Health Services, Inc.	8.80	$ 1.233 Millions	$ 0 Millions
Myriad Genetics Inc	8.31	$ 250.700 Millions	$ 30 Millions
National Vision Holdings Inc	8.26	$ 841.416 Millions	$ 102 Millions
Autolus Therapeutics Plc	8.08	$ 99.009 Millions	$ 12 Millions
The Oncology Institute Inc	8.03	$ 160.655 Millions	$ 20 Millions
Nutriband Inc	7.92	$ 1.082 Millions	$ 0 Millions
Novavax inc	7.61	$ 88.541 Millions	$ 12 Millions
Inogen Inc	7.51	$ 196.617 Millions	$ 26 Millions
Moderna Inc	7.50	$ 1,707.000 Millions	$ 228 Millions
Cardiff Lexington Corporation	7.49	$ 4.042 Millions	$ 1 Millions
Pulse Biosciences Inc	7.45	$ 1.182 Millions	$ 0 Millions
Vanda Pharmaceuticals Inc	7.43	$ 13.506 Millions	$ 2 Millions
Carlsmed Inc	7.42	$ 13.955 Millions	$ 2 Millions
Adaptive Biotechnologies Corporation	7.26	$ 75.254 Millions	$ 10 Millions
Lifemd Inc	7.22	$ 22.284 Millions	$ 3 Millions
Brightspring Health Services Inc	6.35	$ 4,108.953 Millions	$ 647 Millions
Puma Biotechnology Inc	6.29	$ 58.199 Millions	$ 9 Millions
Adm Tronics Unlimited Inc	6.05	$ 1.970 Millions	$ 0 Millions
Sharps Technology Inc	5.68	$ 2.869 Millions	$ 1 Millions
Transmedics Group Inc	5.59	$ 276.120 Millions	$ 49 Millions

Date modified: 2026-09-01T20:16:50+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.